Results 201 to 210 of about 60,295 (253)
The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Sun Q, Zhao G.
europepmc +1 more source
X-linked SEPTIN6-related congenital neutropenia and B cell deficiency. [PDF]
Gunderman LM +12 more
europepmc +1 more source
A machine learning-based prediction model for poor prognosis in sepsis using lymphocyte count: a national, multicenter prospective cohort. [PDF]
Huang S +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annals of Tropical Medicine & Parasitology, 2009
(2009). Lymphopenia in leptospirosis. Annals of Tropical Medicine & Parasitology: Vol. 103, No. 3, pp. 279-282.
Craig, S B +5 more
openaire +3 more sources
(2009). Lymphopenia in leptospirosis. Annals of Tropical Medicine & Parasitology: Vol. 103, No. 3, pp. 279-282.
Craig, S B +5 more
openaire +3 more sources
Lymphopenia in Rheumatoid Arthritis
Journal of the Royal Society of Medicine, 1989Lymphopenia is a recognized but poorly studied feature of rheumatoid arthritis (RA). We set out to establish the prevalence and significance of lymphopenia in RA. A group of 66 RA patients was studied for one year. During this time 10 (15%) had persistent lymphopenia (lymphocyte count less than 1.00 X 10(9)/l) without evidence of Felty's syndrome.
D P, Symmons +3 more
openaire +2 more sources
Immunologically Produced Lymphopenia
Archives of Internal Medicine, 1965IN 1899, Metchnikoff1first produced a leukocytotoxic serum by injecting spleen and lymph node emulsion from rats and guinea pigs into rabbits. Woodruff,2Waksman,3and Hume4employing rabbit antirat or anti guinea pig lymphocytic serum found that lymphopenia could be produced by in vivo administration of this antiserum. Since the production of lymphopenia
C, CHIBA +5 more
openaire +2 more sources
Clinica Chimica Acta, 2011
Interleukin-7 (IL-7) is a growth and anti-apoptotic factor for T-lymphocytes, with potential for clinical use in the treatment of immunodeficiencies due to loss of T-cells. Lymphopenia induced by disease (HIV infection, hemodialysis or Idiopathic CD4+ lymphopenia) or by treatment (high dose chemotherapy or depleting antibodies) for cancer or auto ...
Frederique, Ponchel +2 more
openaire +2 more sources
Interleukin-7 (IL-7) is a growth and anti-apoptotic factor for T-lymphocytes, with potential for clinical use in the treatment of immunodeficiencies due to loss of T-cells. Lymphopenia induced by disease (HIV infection, hemodialysis or Idiopathic CD4+ lymphopenia) or by treatment (high dose chemotherapy or depleting antibodies) for cancer or auto ...
Frederique, Ponchel +2 more
openaire +2 more sources
Scandinavian Journal of Haematology, 1982
Pretreatment peripheral blood lymphocyte counts have been recorded in 181 consecutive untreated patients with histologically proven Hodgkin's disease and the patients followed prospectively to determine the relationship of lymphopenia to survival. Lymphocyte counts at presentation did not correspond with histology type but were lower in stage 4 disease.
B W, Hancock, I R, Dunsmore, H T, Swan
openaire +2 more sources
Pretreatment peripheral blood lymphocyte counts have been recorded in 181 consecutive untreated patients with histologically proven Hodgkin's disease and the patients followed prospectively to determine the relationship of lymphopenia to survival. Lymphocyte counts at presentation did not correspond with histology type but were lower in stage 4 disease.
B W, Hancock, I R, Dunsmore, H T, Swan
openaire +2 more sources

